证券代码：688079 证券简称：美迪凯 公告编号：2025-005 杭州美迪凯光电科技股份有限公司 关于公司及子公司向金融机构申请授信额度及担保 的公告 为了满足公司业务发展的需要，保证项目投资、流动资金周转及日常经营活 动的正常开展，公司及全资子公司、控股子公司拟向金融机构（包含不仅限于金 融机构、融资租赁机构）申请的授信业务总额不超过人民币壹拾伍亿元，实际提 用额度总额不超过人民币壹拾伍亿元。申请授信业务的形式包括但不限于：流动 资金贷款、信用证、金融机构承兑汇票等（上述贷款在总额范围内可滚存发生）。 实际贷款的可用额度最终以金融机构在上述总额范围内审批的额度为准。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ●杭州美迪凯光电科技股份有限公司及全资子公司、控股子公司拟向金融机 构（包含不仅限于金融机构、融资租赁机构）申请授信业务总额不超过人民币壹 拾伍亿元，实际提用额度总额不超过人民币壹拾伍亿元。实际贷款的可用额度最 终以金融机构在上述总额范围内审批的额度为准。 ●在上述预计金融机构贷款总额的范围 ...

目 录 一、募集资金年度存放与使用情况鉴证报告………………………第 1—2 页 二、关于募集资金年度存放与使用情况的专项报告…………… 第 3—12 页 募集资金年度存放与使用情况鉴证报告 天健审〔2025〕7238 号 杭州美迪凯光电科技股份有限公司全体股东： 我们鉴证了后附的杭州美迪凯光电科技股份有限公司（以下简称美迪凯公司） 管理层编制的 2024 年度《关于募集资金年度存放与使用情况的专项报告》。 一、对报告使用者和使用目的的限定 本鉴证报告仅供美迪凯公司年度报告披露时使用，不得用作任何其他目的。 我们同意将本鉴证报告作为美迪凯公司年度报告的必备文件，随同其他文件一起 报送并对外披露。 二、管理层的责任 美迪凯公司管理层的责任是提供真实、合法、完整的相关资料，按照《上市 公司监管指引第 2 号——上市公司募集资金管理和使用的监管要求（2022 年修 订）》（证监会公告〔2022〕15 号）和《上海证券交易所科创板上市公司自律 监管指引第 1 号——规范运作（2023 年 12 月修订）》（上证发〔2023〕194 号） 的规定编制《关于募集资金年度存放与使用情况的专项报告》，并保证其内容真 实、准确、 ...

证券代码：688079 证券简称：美迪凯 公告编号：2025-007 杭州美迪凯光电科技股份有限公司 第二届监事会第十八次会议决议公告 公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 一、监事会会议召开和出席情况 本议案尚需提交公司 2024 年年度股东大会审议。 （二）审议通过《关于公司 2024 年度财务决算报告的议案》 表决结果：同意 3 票，反对 0 票，弃权 0 票。 杭州美迪凯光电科技股份有限公司（以下简称"公司"）第二届监事会第十 八次会议于 2025 年 4 月 28 日以现场方式召开，会议通知于 2025 年 4 月 18 日以 邮件方式送达全体监事。本次会议应到监事 3 人，实际参加会议 3 人，会议由监 事会主席高志坚主持。会议的召集和召开符合《中华人民共和国公司法》和《公 司章程》的有关规定，会议决议合法有效。 二、监事会会议审议情况 经与会监事审议，一致同意通过如下议案： （一）审议通过《关于监事会 2024 年年度工作报告的议案》 表决结果：同意 3 票，反对 0 票，弃权 0 票。 与会监事听取 ...

杭州美迪凯光电科技股份有限公司 2024 年年度利润分配预案公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ●本次不分配利润，不进行资本公积金转增股本。 公司 2024 年度不进行利润分配的原因：2024 年，公司以集中竞价方式回 购股份金额为 5,789,664.80 元（不含印花税、交易佣金等交易费用）。基于公 司 2024 年度业绩亏损、以集中竞价交易方式回购股份的实际情况，综合考量 公司目前经营发展和新项目投入的资金需求，为保持公司稳健发展，更好地维 护全体股东的长远利益，公司 2024 年度利润分配预案为：公司 2024 年度拟不 进行现金分红，不送红股，也不进行资本公积金转增股本。 ●公司 2024 年年度利润分配预案已经公司第二届董事会第二十二次会议和 第二届监事会第十八次会议审议通过，尚需提交公司 2024 年年度股东大会审 议。 ●本次利润分配方案不触及《上海证券交易所科创板股票上市规则（2024 年 4 月修订）》（以下简称《科创板股票上市规则》）第 12.9.1 条第一款第 （八）项 ...

Revenue and Profitability - Revenue for Q1 2025 reached ¥149,496,795.19, an increase of 29.02% compared to ¥115,874,580.90 in the same period last year[4] - Net profit attributable to shareholders was a loss of ¥15,992,072.74, an improvement from a loss of ¥23,558,978.49 year-on-year[4] - Total operating revenue for Q1 2025 reached ¥149,496,795.19, a 29.0% increase from ¥115,874,580.90 in Q1 2024[18] - Net loss for Q1 2025 was ¥16,019,043.08, an improvement from a net loss of ¥24,948,683.53 in Q1 2024[19] - The total comprehensive loss for Q1 2025 was ¥15,967,321.13, an improvement from a loss of ¥24,549,913.32 in Q1 2024[19] - The company reported a basic and diluted earnings per share of -¥0.04 for Q1 2025, compared to -¥0.06 in Q1 2024[19] Cash Flow and Investments - Operating cash flow decreased by 36.76% to ¥15,764,454.78 from ¥24,929,911.36 in the previous year[4] - Cash flow from operating activities generated ¥15,764,454.78 in Q1 2025, down from ¥24,929,911.36 in Q1 2024[21] - Cash flow from investing activities showed a net outflow of ¥90,123,637.57 in Q1 2025, compared to a net outflow of ¥182,875,917.07 in Q1 2024[22] - Cash flow from financing activities generated a net inflow of ¥68,411,055.55 in Q1 2025, down from ¥118,568,697.04 in Q1 2024[22] - The ending cash and cash equivalents balance for Q1 2025 was ¥86,488,506.08, slightly up from ¥85,372,651.19 in Q1 2024[22] Assets and Liabilities - Total assets at the end of the reporting period were ¥3,050,703,579.19, a slight increase of 0.40% from ¥3,038,469,699.24 at the end of the previous year[5] - The company's current assets decreased to RMB 373,431,863.24 from RMB 412,152,468.02, representing a decline of about 9.4%[13] - The total liabilities increased to RMB 1,660,845,944.59 from RMB 1,641,867,096.02, indicating a rise of approximately 1.3%[15] - The company's cash and cash equivalents decreased significantly from RMB 142,333,629.28 to RMB 87,163,687.70, a drop of around 38.8%[13] - Accounts receivable increased to RMB 105,396,966.50 from RMB 99,383,271.74, showing an increase of about 6.4%[13] - Inventory levels rose slightly to RMB 103,781,021.16 from RMB 101,720,926.68, marking an increase of approximately 2.0%[13] - The company's long-term borrowings decreased to RMB 516,848,520.19 from RMB 531,511,526.05, a reduction of about 2.8%[15] - The total equity attributable to the parent company decreased to RMB 1,352,882,867.74 from RMB 1,359,982,454.52, reflecting a decline of approximately 0.5%[15] - The company's short-term borrowings increased to RMB 267,365,726.45 from RMB 213,935,738.87, an increase of about 25.0%[15] - The company reported a decrease in retained earnings to RMB 62,656,797.85 from RMB 78,648,870.59, a decline of approximately 20.3%[15] Research and Development - R&D investment totaled ¥31,569,364.47, representing 21.12% of revenue, a decrease from 21.85% in the previous year[5] - Research and development expenses increased to ¥31,569,364.47 in Q1 2025, up from ¥25,321,434.65 in Q1 2024[18] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 10,191[10] - The largest shareholder, Hangzhou Meidike Self-owned Capital Investment Partnership, holds 40.61% of the shares[10] Other Financial Highlights - The company reported a non-recurring gain of ¥116,297.52 after tax, primarily from government subsidies and other non-operating income[6] - The increase in revenue was mainly driven by sales growth in optoelectronic and semiconductor packaging products[7] - The weighted average return on equity improved to -1.18% from -1.62% year-on-year[5]

Financial Performance - The net profit attributable to the parent company for 2024 was -101,845,842.42 RMB, while the net profit for the parent company was -4,947,767.23 RMB[5]. - The company plans not to distribute cash dividends, issue bonus shares, or increase capital reserves due to the losses incurred in 2024[5]. - The company is currently not profitable and has not achieved profitability since its listing[3]. - The net profit attributable to shareholders of the listed company was CNY -101.85 million, compared to CNY -84.45 million in 2023[21]. - The net cash flow from operating activities decreased by 40.14% to CNY 76.73 million[21]. - The company reported a basic earnings per share of CNY -0.26 for 2024, compared to CNY -0.21 in 2023[22]. - The company reported a non-recurring loss of approximately ¥8.76 billion in 2024, compared to a loss of ¥9.29 billion in 2023[29]. - The total amount of trading financial liabilities decreased from approximately ¥10.93 million at the beginning of the period to zero at the end of the period[31]. - The company’s cash dividend amount for the last three fiscal years is recorded as 0, indicating no cash dividends were distributed[186]. - The company’s cash buyback amount included in cash dividends for the last fiscal year was 5,789,664.80 RMB[184]. Revenue and Growth - The company achieved operating revenue of CNY 485.51 million in 2024, a year-on-year increase of 51.38%[21]. - The company’s operating revenue for the reporting period was 485.51 million yuan, an increase of 51.38% compared to the same period last year[106]. - Semiconductor optoelectronics revenue grew by 181.45% year-on-year, driven by the mass production of the 12-inch ultrasonic fingerprint recognition chip[110]. - Micro-nano electronics revenue surged by 585.19% year-on-year, mainly due to the ramp-up of production capacity for RF filter chips[112]. - The revenue from semiconductor packaging increased by 194.55% year-on-year, reflecting significant growth in the production of RF chip packaging and ultrasonic fingerprint recognition chip packaging[112]. - The company reported a revenue of 1,182.57 million for the TC-SAW micro circuit technology, with a growth of 349.53% compared to the previous period[84]. Research and Development - The company invested a total of 107.72 million yuan in R&D, accounting for 22.19% of its sales revenue, with 150 dedicated R&D personnel, representing 13.49% of the total workforce[39]. - Cumulative R&D investment over the last three fiscal years amounted to 265,570,166.92 RMB, representing 21.77% of total cumulative revenue[186]. - The company has applied for a total of 354 patents domestically and internationally, with 245 granted and 215 valid patents as of the end of the reporting period[39]. - The company has developed core technologies in precision optics, semiconductor acousto-optics, semiconductor micro-nano circuits (mainly MEMS), semiconductor packaging, and micro-nano optics[75]. - The company is focusing on R&D that aligns with customer needs and market trends, ensuring timely feedback and response[96]. Market and Strategic Focus - The company plans to focus on the optical optoelectronics and semiconductor industries, leveraging existing core technologies and high-quality customer resources to seize opportunities from technological trends such as AI, smart cars, 5G, and the metaverse[144]. - By 2025, the company aims to enhance its business expansion efforts, emphasizing innovation in processes, technology, and management, while developing new technologies, products, and businesses[145]. - The company intends to optimize its product structure and enhance profitability by focusing on differentiated product strategies and expanding its presence in the semiconductor acousto-optics and MEMS markets[146]. - Key investments will be made in semiconductor wafer manufacturing and packaging projects to optimize product structure and enhance core competitiveness[148]. Risk Management - The company has detailed various risks and countermeasures in the report, which can be found in the "Management Discussion and Analysis" section[3]. - The company faces risks related to rapid product technology iteration and potential loss of core personnel[98]. - The company is exposed to macroeconomic risks, including global economic fluctuations and international trade tensions[105]. Corporate Governance and Compliance - The company has established a robust internal control system and governance structure to ensure compliance with relevant laws and regulations, thereby protecting shareholder interests[150]. - The company has implemented key performance indicators across various operational areas to ensure continuous improvement[95]. - The company has no reported risks or dissenting opinions from the Supervisory Board[173]. Employee and Management Structure - The company reported a total of 1,112 employees, with 208 in the parent company and 904 in major subsidiaries[173]. - The company has a structured approach to remuneration that complies with relevant laws and regulations, ensuring no adverse impact on shareholder interests[162]. - The company has implemented a stock option and restricted stock incentive plan for 2024, linking executive performance to company performance[200]. - The total number of shares granted under the 2024 stock option and restricted stock incentive plan represents 2.17% of the total shares outstanding, which is 406,737,698 shares[188]. Future Outlook - The company provided an optimistic outlook for Q4 2023, projecting a revenue growth of 20% compared to Q3 2023[156]. - New product launches are expected to contribute an additional 100 million RMB in revenue in the next quarter[156]. - The management team emphasized a commitment to sustainability, aiming for a 30% reduction in carbon emissions by 2025[156].

证券代码：688079 证券简称：美迪凯 公告编号：2025-006 杭州美迪凯光电科技股份有限公司 关于提请股东大会授权董事会以简易程序向 特定对象发行股票的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 一、本次授权事宜概述 根据相关法律法规和规范性文件的规定，杭州美迪凯光电科技股份有限公 司（以下简称"公司"）于 2025 年 4 月 28 日召开第二届董事会第二十二次会 议，审议通过了《关于提请股东大会授权董事会以简易程序向特定对象发行股 票的议案》，同意公司董事会提请股东大会授权董事会决定向特定对象发行融 资总额不超过人民币三亿元且不超过最近一年末净资产百分之二十的股票。授 权期限自 2024 年年度股东大会通过之日起至 2025 年年度股东大会召开之日 止。 本议案尚须提交公司股东大会审议通过。 二、本次授权事宜具体内容 本次授权事宜包括但不限于以下内容： 本次发行股票采用以简易程序向特定对象发行的方式，发行对象为符合中 国证监会规定的证券投资基金管理公司、证券公司、信托公司、财务公司、保 险机构投资者、合格 ...

证券代码：688079 证券简称：美迪凯 公告编号：2025-003 杭州美迪凯光电科技股份有限公司 2024 年度业绩快报公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 本公告所载2024年度主要财务数据为初步核算数据，未经会计师事务所审 计，具体数据以公司2024年年度的定期报告为准，提请投资者注意投资风险。 一、2024 年度主要财务数据和指标 注：1.本报告期初数同法定披露的上年年末数。 2.上述财务数据及指标为未经审计的合并报表数据，最终数据以公司 2024 年年度报告中披露数据为准。 二、经营业绩和财务状况情况说明 （一）报告期的经营情况、财务状况及影响经营业绩的主要因素 1、报告期的经营情况以及财务状况 公司 2024 年度实现营业收入 48,658.94 万元，较上年同期增加 16,586.48 万元，同比增长 51.72%；实现归属于母公司所有者的净利润-9,830.54 万元，较 上年同期减少 1,385.45 万元；实现归属于母公司所有者的扣除非经常性损益的 净利润-8,888.18 万元，较上 ...

大股东持股的基本情况 本次减持计划实施前，杭州美迪凯光电科技股份有限公司（以下简称"公司"） 股东香港豐盛佳美（國際）投資有限公司（以下简称"丰盛佳美"）持有公司股 份 36,903,624 股，占公司当时总股本的 9.20%。上述股份来源为公司 IPO 前取 得股份，且已于 2022 年 3 月 2 日解除限售并上市流通。 减持计划的主要内容及实施情况 2024 年 10 月 31 日, 公司披露了《杭州美迪凯光电科技股份有限公司 5%以 上股东减持股份计划公告》（公告编号：2024-057），公司股东丰盛佳美拟自公 告之日起的十五个交易日后三个月内（2024 年 11 月 21 日至 2025 年 2 月 20 日），通过集中竞价和大宗交易方式减持合计不超过 12,039,999 股公司股份， 即不超过公司当时总股本的 3%。其中， 以集中竞价方式减持不超过 4,013,333 股（不超过公司当时股份总数的 1%），以大宗交易方式减持不超过 8,026,666 股（不超过公司当时股份总数的 2%）。 截至本公告披露日，丰盛佳美已通过集中竞价减持股份 4,013,333 股，占公 司当前总股本的 0.986 ...

Financial Projections - The company expects to achieve an operating revenue of approximately 486.87 million yuan in 2024, an increase of about 166.15 million yuan or 51.80% compared to the previous year[2] - The projected net profit attributable to the parent company for 2024 is approximately -98.93 million yuan, with a net profit of -90.07 million yuan after deducting non-recurring gains and losses[2] - EBITDA for 2024 is expected to be around 54.43 million yuan, representing an increase of approximately 36.43 million yuan or 202.34% year-over-year[2] Revenue Breakdown - The revenue from semiconductor acousto-optic products is expected to be around 78.93 million yuan, an increase of approximately 50.88 million yuan compared to the previous year[6] - Revenue from micro-nano electronic products is projected to be about 58.08 million yuan, an increase of approximately 49.60 million yuan year-over-year[6] Expenditure and Costs - The company plans to increase R&D expenditure to approximately 107.58 million yuan in 2024, an increase of about 22.24 million yuan compared to the previous year[7] - Depreciation expenses for 2024 are expected to be around 148.67 million yuan, an increase of approximately 36.62 million yuan year-over-year[7] - Labor costs are projected to rise to approximately 148.45 million yuan in 2024, an increase of about 40.09 million yuan compared to the previous year[7] - Interest expenses are expected to be around 26.62 million yuan in 2024, an increase of approximately 19.73 million yuan year-over-year[7] Equity Incentive Plan - The company has implemented an equity incentive plan, resulting in an increase in share-based payment expenses of approximately 5.16 million yuan[7]